Published 12/11/19 on Tech Transfer eNews Blog A start-up from the University of Maryland-Baltimore (UMB) is advancing a treatment for inflammatory and age-related diseases. GEn1E Lifesciences is based on a p38a kinase inhibitor program developed at UMB. The start-up aims …
Published 12/3/19 on PRNewswire PALO ALTO, Calif. and BALTIMORE, Dec. 3, 2019 /PRNewswire/ — GEn1E Lifesciences Inc., a Y Combinator-backed biotech startup focused on curing inflammatory and age-related diseases, announced today that it has acquired an exclusive, worldwide and all-fields license to the University of …
Published 11/26/19 on UMB News Keith Ohlinger, 50, owner of Porch View Farm in Howard County, got straight to the point. “Farming is hard work,” he told the sold-out crowd at the fifth annual Agricultural and Environmental Law Conference held …
Published in the Baltimore Sun, 11/21/19 Few people associate hospitals with anything resembling joy or creativity. The inherent grimness of places like the Shock Trauma Center at the University of Maryland — perhaps the leastfundestination in downtown Baltimore — made the happy …
Yu lab developing novel analytical technologies for biopharmaceutical products in collaboration with industry partners Merck and Pfizer Published on PR Newswire, 11/19/19 ROCKVILLE, Md., Nov. 19, 2019 /PRNewswire/ — Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received two awards totaling $1.1M from the Food …
Published 11/18/19 in the Baltimore Business Journal A Pigtown-based company that markets high-caffeine, energizing tea blends is raising $2 million in new funding. Zest Tea’s new round was disclosed in a recent filing with the U.S. Securities and Exchange Commission. …
Published 10/24/19 on Technical.ly Baltimore The Small Business Innovation Research grant will help the company validate its device that uses ultrasound for feeding tube placement with a trial at University of Maryland Medical Center. A medical device startup that was …
Published by UM Ventures, 10/21/19 BALTIMORE, Md., Oct. 21, 2019 (GLOBE NEWSWIRE) — CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded the company a two-year, …
Published 10/17/19 in Technical.ly Baltimore The biotech company is developing a cell therapy that could help patients who have suffered a heart attack. It’s the latest company led by medtech entrepreneur Bill Niland. NeoProgen, a Baltimore-based company led by medtech …